Oral Caffeine Use for Pain Management in AIS Patients After Spinal Fusion

PHASE4CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

December 11, 2019

Primary Completion Date

January 20, 2024

Study Completion Date

August 1, 2024

Conditions
Adolescent Idiopathic Scoliosis
Interventions
DRUG

Caffeine Tablet

Caffeine is approved by the FDA as a stimulant. A stimulant approved by the United States Food and Drug Administration (FDA) for the treatment to increase mental alertness and in combination with painkiller to treat migraine headaches. It is approved in the form of pill or tablet.

DRUG

Placebo

Placebo, empty opaque dark blue blank capsule, taken twice daily. This will be an adjuvant to their standard pain control.

Trial Locations (1)

64114

Children'S Mercy Hospitals & Clinic, Kansas City

All Listed Sponsors
lead

Children's Mercy Hospital Kansas City

OTHER

NCT04950660 - Oral Caffeine Use for Pain Management in AIS Patients After Spinal Fusion | Biotech Hunter | Biotech Hunter